TY - CHAP
T1 - Neurotrophin Regulation and Signaling in Airway Smooth Muscle
AU - Roos, Benjamin B.
AU - Teske, Jacob J.
AU - Bhallamudi, Sangeeta
AU - Pabelick, Christina M.
AU - Sathish, Venkatachalem
AU - Prakash, Y. S.
N1 - Funding Information:
Acknowledgments This work was supported by grants from the US National Institutes of Health R01 HL088029 (Prakash), R01 HL142061 (Pabelick, Prakash), and R01 HL146705 (Sathish).
Publisher Copyright:
© 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.
PY - 2021
Y1 - 2021
N2 - Structural and functional aspects of bronchial airways are key throughout life and play critical roles in diseases such as asthma. Asthma involves functional changes such as airway irritability and hyperreactivity, as well as structural changes such as enhanced cellular proliferation of airway smooth muscle (ASM), epithelium, and fibroblasts, and altered extracellular matrix (ECM) and fibrosis, all modulated by factors such as inflammation. There is now increasing recognition that disease maintenance following initial triggers involves a prominent role for resident nonimmune airway cells that secrete growth factors with pleiotropic autocrine and paracrine effects. The family of neurotrophins may be particularly relevant in this regard. Long recognized in the nervous system, classical neurotrophins such as brain-derived neurotrophic factor (BDNF) and nonclassical ligands such as glial-derived neurotrophic factor (GDNF) are now known to be expressed and functional in non-neuronal systems including lung. However, the sources, targets, regulation, and downstream effects are still under investigation. In this chapter, we discuss current state of knowledge and future directions regarding BDNF and GDNF in airway physiology and on pathophysiological contributions in asthma.
AB - Structural and functional aspects of bronchial airways are key throughout life and play critical roles in diseases such as asthma. Asthma involves functional changes such as airway irritability and hyperreactivity, as well as structural changes such as enhanced cellular proliferation of airway smooth muscle (ASM), epithelium, and fibroblasts, and altered extracellular matrix (ECM) and fibrosis, all modulated by factors such as inflammation. There is now increasing recognition that disease maintenance following initial triggers involves a prominent role for resident nonimmune airway cells that secrete growth factors with pleiotropic autocrine and paracrine effects. The family of neurotrophins may be particularly relevant in this regard. Long recognized in the nervous system, classical neurotrophins such as brain-derived neurotrophic factor (BDNF) and nonclassical ligands such as glial-derived neurotrophic factor (GDNF) are now known to be expressed and functional in non-neuronal systems including lung. However, the sources, targets, regulation, and downstream effects are still under investigation. In this chapter, we discuss current state of knowledge and future directions regarding BDNF and GDNF in airway physiology and on pathophysiological contributions in asthma.
KW - Asthma
KW - Brain-derived neurotrophic factor
KW - Calcium
KW - Contractility
KW - Glial-derived neurotrophic factor
KW - Lung disease
KW - Remodeling
UR - http://www.scopus.com/inward/record.url?scp=85107046584&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107046584&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-68748-9_7
DO - 10.1007/978-3-030-68748-9_7
M3 - Chapter
C2 - 34019266
AN - SCOPUS:85107046584
T3 - Advances in Experimental Medicine and Biology
SP - 109
EP - 121
BT - Advances in Experimental Medicine and Biology
PB - Springer
ER -